EUVIMED · CrossrefZeitschrift
Journal of Immunotherapy and Precision Oncology
ISSN 2590-017X · Innovative Healthcare Institute
Neueste Artikel
Outcomes of Patients with Rare Cancers Treated with Immune Checkpoint Inhibitors with and Without Lung and/or Liver Metastases (NCI/SWOG S1609)
State of Precision Oncology: An Australian Perspective
Molecular Profiling in Asia: The Current Status and Approach
Molecular Profiling and Precision Oncology for Non–Small Cell Lung Cancer in Latin America: Unique Epidemiology, Persistent Barriers, and Paths Toward Equity
Clinical, Radiologic, and Highest-Grade Assessment of Immune Checkpoint Inhibitor Pneumonitis in Non–Small Cell Lung Cancer
Evidence for Dose Optimization of Immune Checkpoint Inhibitors
Moving Beyond the Plateau in Immune Checkpoint Inhibition—The Imperative of Early Referral and Precision Strategies
Response to RAF/MEK/ERK Inhibitors in Patients with RAS-Altered and Wild-Type Tumors
The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact
From Promise to Precision: The Next Chapter of Checkpoint Inhibition
A Case Series of Raynaud’s Phenomenon in the Setting of Immune Checkpoint Inhibitors
Trastuzumab Deruxtecan-Associated Pneumonitis in Non-Breast Solid Tumors: A Retrospective Cohort Study
Colonic Polyp Regression After Nous-209 Cancer Immunotherapy: A Clinical Trial Case Report
Exceptional Response to Immunotherapy-based Treatment in Compound EGFR-Mutated Oligometastatic Pulmonary Sarcomatoid Carcinoma: A Case Report
Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies
Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions
T cell Immunoglobulin and Mucin Domain Containing Protein 3 (TIM-3) Inhibitors in Oncology Clinical Trials: A Review
Therapeutic Role of Synthetic Lethality in ARID1A -Deficient Malignancies
Oral Toxicities Associated with Immune Checkpoint Inhibitors: Meta-Analyses of Clinical Trials
B7-H3 Inhibitors in Oncology Clinical Trials: A Review
Sustained Clinical Response to Immunotherapy Followed by BET Inhibitor in a Patient with Unresectable Sinonasal NUT Carcinoma
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma
A Review of Scheduling Strategies for Radiotherapy and Immune Checkpoint Inhibition in Locally Advanced Rectal Cancer
Treatment of Stage IV Non–Small Cell Lung Cancer with Pembrolizumab in Combination with Platinum-Based Doublet Chemotherapy in Vietnam
Highlights on Ocular Toxicity of Immune Checkpoint Inhibitors at a US Tertiary Cancer Center
Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A review
Role of Abdominal and Pelvic CT Scans in Diagnosis of Patients with Immunotherapy-Induced Colitis
Case Report: Nivolumab-Induced Autoimmune Pancreatitis
Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitors
Clinicopathologic Features and Whole Genome Sequencing of a Primary Osteosarcoma of the Uterus
EUVIMED